|1.||Izard, Jean-Claude: 4 articles (11/2012 - 05/2008)|
|2.||Lizard, Gérard: 2 articles (06/2009 - 05/2008)|
|3.||Delmas, Dominique: 2 articles (06/2009 - 05/2008)|
|4.||Latruffe, Norbert: 2 articles (06/2009 - 05/2008)|
|5.||Carillon, Julie: 1 article (11/2012)|
|6.||Romain, Cindy: 1 article (11/2012)|
|7.||Rouanet, Jean-Max: 1 article (11/2012)|
|8.||Gaillet, Sylvie: 1 article (11/2012)|
|9.||Ramos, Jeanne: 1 article (11/2012)|
|10.||Vidé, Joris: 1 article (11/2012)|
02/01/2006 - "Pretreatment (5 min) of vineatrol (10, 20 and 40 mg/kg i.p.) could not inhibit the convulsions though the latency was significantly increased with 20 and 40 mg/kg. However when the drug was administrated 5 min prior and repeated at 30 and 90 min after kainic acid there was significant reduction in incidence of convulsions. "
02/01/2006 - "The aim of the present study was to evaluate the effect of an antioxidant vineatrol against kainic acid-induced seizures, markers of oxidative stress and expression of heat shock protein in brain. "
02/01/2006 - "Protective effect of vineatrol against kainic acid induced seizures, oxidative stress and on the expression of heat shock proteins in rats."
10/01/2009 - "The present study was carried out to examine the effect of administration of vineatrol in the middle cerebral artery (MCA) occlusion model of stroke in rats. "
10/01/2009 - "The results demonstrate that administration of vineatrol is able to reduce the neuronal damage caused by focal ischemia in the MCA occlusion model of stroke in rats."
|3.||Status Epilepticus (Complex Partial Status Epilepticus)
11/07/2012 - "We evaluated the effect of the intake of a grapevine-shoot phenolic extract (Vineatrol 30) on early atherosclerosis in hamsters fed a hyperlipidic diet. "
11/07/2012 - "Vineatrol and cardiovascular disease: beneficial effects of a vine-shoot phenolic extract in a hamster atherosclerosis model."
|5.||Prostatic Neoplasms (Prostate Cancer)
10/01/2010 - "Here we provide the first evidence that dietary agents, namely, epigallocatechin gallate (EGCg, IC(50)≈75 μM), resveratrol (IC(50)≈40 μM), or a mixture of polyphenols from green tea [polyphenon E (PPE), IC(50)≈70 μM] or grapevine extract (vineatrol, IC(50)≈30 μM), impede prostate cancer cell growth in vitro and in vivo by inhibiting the SphK1/S1P pathway. "
|1.||Kainic Acid (Kainate)
|2.||Heat-Shock Proteins (Heat-Shock Protein)
|5.||Interleukin-6 (Interleukin 6)
|9.||epigallocatechin gallate (epigallocatechin-3-gallate)